Edition:
United States

Protalex Inc (PRTX.PK)

PRTX.PK on OTC Markets Group

0.70USD
--
Change (% chg)

-- (--)
Prev Close
$0.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,466
52-wk High
$3.50
52-wk Low
$0.55

Latest Key Developments (Source: Significant Developments)

Protalex Inc announces regulatory approval to initiate phase ib trial of prtx-100
Monday, 5 Oct 2015 08:00am EDT 

Protalex Inc:Announces regulatory approval to initiate phase ib trial of prtx-100 to treat immune thrombocytopenia in France.  Full Article

More From Around the Web

No consensus analysis data available.